Cost-effectiveness of oral ondansetron for children with acute gastroenteritis in primary care:a randomised controlled trial

Background Acute gastroenteritis is a common childhood condition with substantial medical and indirect costs, mostly because of referral, hospitalisation, and parental absence from work. Aim To determine the cost-effectiveness of adding oral ondansetron to care as usual (CAU) for children with acute gastroenteritis presenting to out-of-hours primary care (OOH-PC). Design and setting A pragmatic randomised controlled trial from December 2015 to January 2018, at three OOH-PC centres in the north of the Netherlands (Groningen, Zwolle, and Assen) with a follow-up of 7 days. Method Children were re... Mehr ...

Verfasser: Weghorst, Anouk A. H.
Holtman, Gea A.
Bonvanie, Irma J.
Wolters, Pien
Kollen, Boudewijn J.
Vermeulen, Karin M.
Berger, Marjolein Y.
Dokumenttyp: Artikel
Erscheinungsdatum: 2021
Reihe/Periodikum: Weghorst , A A H , Holtman , G A , Bonvanie , I J , Wolters , P , Kollen , B J , Vermeulen , K M & Berger , M Y 2021 , ' Cost-effectiveness of oral ondansetron for children with acute gastroenteritis in primary care : a randomised controlled trial ' , British Journal of General Practice , vol. 71 , no. 711 , pp. E736-E743 . https://doi.org/10.3399/BJGP.2020.1093
Schlagwörter: acute gastroenteritis / child / cost-effective / ondansetron / primary care / vomiting / NETHERLANDS / GUIDELINES
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26825292
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://hdl.handle.net/11370/55eb317f-964c-4fd5-a8ab-1cc50887b87c

Background Acute gastroenteritis is a common childhood condition with substantial medical and indirect costs, mostly because of referral, hospitalisation, and parental absence from work. Aim To determine the cost-effectiveness of adding oral ondansetron to care as usual (CAU) for children with acute gastroenteritis presenting to out-of-hours primary care (OOH-PC). Design and setting A pragmatic randomised controlled trial from December 2015 to January 2018, at three OOH-PC centres in the north of the Netherlands (Groningen, Zwolle, and Assen) with a follow-up of 7 days. Method Children were recruited at the OOH-PC and parents kept a parental diary. Inclusion criteria were: aged 6 months-6 years; diagnosis of acute gastroenteritis; at least four reported episodes of vomiting 24 hours before presentation, at least one of which was in the 4 hours before presentation; and written informed consent from both parents. Children were randomly allocated at a 1:1 ratio to either CAU (oral rehydration therapy) or CAU plus one dose of 0.1 mg/kg oral ondansetron. Results In total, 194 children were included for randomisation. One dose of oral ondansetron decreased the proportion of children who continued vomiting within the first 4 hours from 42.9% to 19.5%, (a decrease of 54.5%), with an odds ratio of 0.4 (95% confidence interval [CI] = 0.2 to 0.7; number needed to treat: four). Total mean costs in the ondansetron group were 31.2% lower ((sic)488 [420] pound versus (sic)709 [610]) pound, and the total incremental mean costs for an additional child free of vomiting in the first 4 hours was -(sic)9 (8) pound (95% CI = -(sic)41 [35] pound to (sic)3 [3]) pound. Conclusion A single oral dose of ondansetron for children with acute gastroenteritis, given in OOH-PC settings, is both clinically beneficial and cost-effective.